Systemic Lupus Erythematosus News

• Post Roe, New Worries About Meds Linked to Birth Defects Physicians fear that women won't get the best treatments or will face dangerous risks.
  Medscape Medical News, June 29, 2022
• Roe Reversal May Go Well Beyond Abortion Experts fear that many reproductive procedures will be imperiled as states start banning pregnancy terminations.
  Medscape Medical News, June 24, 2022
• Azathioprine Discontinuation Linked to Genotype Regardless of Race Across multiple disease settings, patients with the rs2814778-CC genotype face a higher risk of stopping azathioprine due to hematopoietic toxicity and receiving lower doses of thiopurines, regardless of race, a new study suggests.
  Reuters Health Information, June 20, 2022
• New Blood Tests Approved for Lupus, Systemic Sclerosis Diagnoses The Food and Drug Administration has approved a new diagnostic blood test to detect monospecific Ribosomal P antibodies to support a diagnosis of systemic lupus erythematosus.
  WebMD Health News, June 17, 2022
• EULAR 2022 Deucravacitinib and Orelabrutinib Perform Well in Lupus Trials Disease activity was reduced by treatment with either of the novel investigational agents in two separate early clinical trials, with further trials planned.
  Medscape Medical News, June 10, 2022
• EULAR 2022 Continuing, Stopping Immunosuppression Tested in Lupus Nephritis Risk of renal relapse and SLE flares was greater in patients with lupus nephritis who discontinued rather than continued immunosuppressive therapy.
  Medscape Medical News, June 09, 2022
• EULAR 2022 High Maternal, Fetal Morbidity Rates in SLE Pregnancies Despite steady declines in maternal and fetal mortality among pregnant women with systemic lupus erythematosus (SLE), maternal and fetal morbidities remain high.
  Medscape Medical News, June 02, 2022
• CARRA 2022 Lupus Mutation May Unlock Targeted Drugs for Patient Subset A new study provides definitive proof of one pathway that contributes to lupus, though it’s unclear how many patients with lupus are affected by this mechanism.
  Medscape Medical News, June 01, 2022
• EULAR 2022 EULAR Congress Opens New Avenues for Learning, Collaborating New and slightly altered session formats break new ground in the first-time hybrid congress, taking place June 1-4 in Copenhagen, Denmark, and virtually.
  Medscape Medical News, May 26, 2022
• Abortion Debate May Affect Rx Decisions for Pregnant Women Enactment of abortion restrictions in a growing number of states could have a chilling effect on therapy regimens in pregnant women and their desire to participate in clinical trials.
  Medscape Medical News, May 26, 2022
• Does He Have Back Pain or Rheumatism? The search for evidence of inflammatory conditions is difficult, even for experts. One expert explains how this search can be successful.
  Medscape Medical News, May 18, 2022
• CARRA 2022 Pfizer COVID Vax Performs Well in Youth With Rheumatic Diseases Nearly all participants in the study showed complete seroconversion, in contrast to similar studies in adults.
  Medscape Medical News, May 17, 2022
• Lenabasum Improved Skin Symptoms, in Small Dermatomyositis Trial In the phase 2 trial, skin biopsies before and after treatment showed significant reductions in inflammatory cytokines relevant to dermatomyositis pathogenesis.
  Medscape Medical News, May 13, 2022
• Relugolix Combo Eases Long-Neglected Fibroid Symptom: Pain Combination therapy with relugolix (Orgovyx, Relumina), a gonadotropin-releasing hormone antagonist, significantly reduced the pain of uterine fibroids in a new study.
  Medscape Medical News, May 11, 2022
• Maternal Autoimmune Diseases Up Risk of Mental Illness in Children The risk of mental disorders was 16% higher in offspring whose mothers had autoimmune diseases such as diabetes and rheumatoid arthritis, a new study found.
  Medscape Medical News, May 03, 2022
• BSR 2022 Lupus May Lead to Worse Stroke Outcomes for Women, but Not Men Women with systemic lupus erythematosus (SLE) were 20% more likely to have a prolonged hospital stay and 28% less likely to have a routine home discharge, compared with patients who did not have SLE.
  Medscape Medical News, April 29, 2022
• Women in Rheumatology: A Look Back, a Look Forward This article takes a look at women's impact on the specialty in research, education, patient care, and leadership, as well as the evolving challenges they face.
  Medscape Medical News, April 22, 2022
• Children With RMDs Not at High Risk for Severe COVID-19 A study of children and young people with rheumatic and musculoskeletal diseases and COVID-19 showed that the majority had mild symptoms and that the hospitalization rate was low.
  Medscape Medical News, April 13, 2022
• JIA Disease Activity, Disability Linked to Social Factors For patients with juvenile idiopathic arthritis (JIA), levels of disease activity and disability vary, depending on family income, education level, and other social factors.
  Medscape Medical News, April 07, 2022
• For the Immunocompromised, COVID Remains a Major Threat 'It's just really scary as an immunocompromised person to not know what you're going to be presented with and how to prepare,' said Heather Benjamin, an immunocompromised woman in Burlington, Vermont.
  WebMD Health News, April 07, 2022